|
WO2015185240A1
|
|
Compositions containing simvastatin in omega-3 polyunsaturated fatty acids
|
|
JP2015025004A
|
|
Acetyl l-carnitine for preventing painful peripheral diabetic neuropathy
|
|
WO2015011008A1
|
|
7-azaindole derivatives as parp inhibitors
|
|
WO2014122222A1
|
|
Hydroxamate derivatives bearing amide-lactams as potent hdac inhibitors and their uses as medicaments
|
|
WO2014095628A1
|
|
Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
|
|
US2015252120A1
|
|
Modified hyaluronic acid derivatives and use thereof
|
|
US2014024712A1
|
|
Acetyl L-carnitine for the preparation of a medicament for the prevention of painful peripheral neuropathy in patients with type 2 diabetes
|
|
EP2842557A1
|
|
Mildronate in ophthalmic disorders
|
|
EP2783695A1
|
|
Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
|
|
NZ620202A
|
|
Pharmaceutical composition of oxidised avidin suitable for inhalation
|
|
NZ617294A
|
|
Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline
|
|
TW201300119A
|
|
Composition useful for the treatment of lipid metabolism disorders
|
|
RS54100B1
|
|
Composition useful for the treatment of lipid metabolism disorders
|
|
BR112013028163A2
|
|
composition useful for the treatment of disorders of lipid metabolism
|
|
WO2012084446A1
|
|
Compound having antibacterial activity
|
|
WO2012076352A1
|
|
Composition for topical use for treating skin disorders
|
|
EP2586438A1
|
|
Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine
|
|
NZ609769A
|
|
Diterpenoid derivatives endowed of biological properties
|
|
EP2642991A1
|
|
Therapeutical method for the treatment of the leber optic
|
|
EP2588137A1
|
|
Fimh vaccine against urinary tract infections (uti)
|
